MedPath

Effect of Tripterygium wilfordii polyglycoside tablets on the inhibition of TM on complement pathway and related inflammatory markers in membranous nephropathy

Phase 1
Not yet recruiting
Conditions
idiopathic membranous nephropathy
Registration Number
ITMCTR2000003816
Lead Sponsor
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. The clinical and pathological diagnosis was membranous nephropathy;
2. Aged 18-90 years old;
3. the patient was hospitalized within 24 hours after the onset of the disease;
4. there was no history of heart, liver dysfunction, severe anemia, leucopenia and thrombocytopenia.

Exclusion Criteria

1. acute and chronic kidney diseases other than membranous nephropathy;
2. long-term immobilization;
3. recent surgery and blood transfusion;
4. incomplete clinical data;
5. heart and liver dysfunction;
6. severe anemia, leukopenia and thrombocytopenia;
7. patients with active gastric and duodenal ulcer;
8. severe arrhythmia;
9. children, child-bearing age with pregnancy requirements, pregnant women and lactation woman.

Study & Design

Study Type
Diagnostic test
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.